# Mira Pharmaceuticals, Inc.: Form 8-K, filed Aug 6, 2026

- Company: [Mira Pharmaceuticals, Inc.](/companies/mira.md) (CIK 1904286)
- Form: 8-K
- Filed: 2026-08-06
- Accepted by EDGAR: Aug 6, 2026, 12:00 ET
- Period: 2026-08-06
- Accession: 0001493152-26-036262
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1904286/000149315226036262/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1904286/000149315226036262/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1904286/000149315226036262/form8-k.htm

Filed Aug 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-036262. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.